CriquiMHFronekABarrett-ConnorE. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985; 71: 510–515.
2.
CriquiMHLangerRDFronekA. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med.1992; 326: 381–386.
3.
McDermottMMMehtaSAhnH. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med.1997; 12: 209–215.
4.
HirschATCriquiMHTreat-JacobsonD. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286: 1317–1324.
5.
CriquiMHFronekAKlauberMR. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasive testing in a defined population. Circulation. 1985; 71: 516–522.
6.
KannelWBMcGeeDL. Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc.1985; 33: 13–18.
7.
FowkesFGHousleyECawoodEH. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol.1991; 20: 384–392.
8.
DormandyJRutherfordRB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg.2000; 31: S1–S296.
